Gerstmann-Straussler-Scheinker Disease

Gerstmann-Straussler-Scheinker disease is a rare neurodegenerative disorder caused by prions and characterized by symptoms similar to other prion-associated diseases. Here is the latest research.

December 21, 2019
Open Access

Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity

Vinothkumar RajanJason N Berman
February 7, 2020
Open Access

Obesity significantly alters the human sperm proteome, with potential implications for fertility

Journal of Assisted Reproduction and Genetics
T PiniM Katz-Jaffe
November 27, 2020

Inflammatory and Antioxidant Gene Transcripts: A Novel Profile in Postoperative Atrial Fibrillation

Seminars in Thoracic and Cardiovascular Surgery
Tessa M F WattMichigan Mitral Research Group (MMRG)
June 24, 2020
Open Access

Diagnosis of Prion Diseases by RT-QuIC Results in Improved Surveillance

Daniel D RhoadsBrian Stephen Appleby
December 22, 2020

Familial Prion Disease: First Indian Kindred with Gerstmann-Sträussler-Scheinker Syndrome

Neurology India
Sameer BhatiaMandaville Gourie-Devi
August 27, 2019
Case Report

Granulomatous slack skin: case report with electron microscopic features

Dermatology Online Journal
Bo WangHong-Wei Wang
December 29, 2020
Open Access

Genetic sexing strains for the population suppression of the mosquito vector Aedes aegypti

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
Panagiota KoskiniotiKostas Bourtzis
March 12, 2020
Open Access

TeaMiD: a comprehensive database of simple sequence repeat markers of tea

Database : the Journal of Biological Databases and Curation
Himanshu DubeyTapan Kumar Mondal
April 18, 2020
Open Access

Isolation of infectious, non-fibrillar and oligomeric prions from a genetic prion disease

Brain : a Journal of Neurology
Ilaria VanniRomolo Nonno
December 19, 2019
Open Access

Medfly-Wolbachia symbiosis: genotype x genotype interactions determine host's life history traits under mass rearing conditions

BMC Biotechnology
Georgios A KyritsisNikos T Papadopoulos
March 14, 2020

Accumulation of Astrocytic Aquaporin 4 and Aquaporin 1 in Prion Protein Plaques

Journal of Neuropathology and Experimental Neurology
Shoko SadashimaToru Iwaki
December 25, 2019

Movement Disorders in Prionopathies: A Systematic Review

Tremor and Other Hyperkinetic Movements
Federico Rodriguez-PorcelAlberto J Espay
December 17, 2020
Open Access

Structural Features of Heparin and Its Interactions With Cellular Prion Protein Measured by Surface Plasmon Resonance

Frontiers in Molecular Biosciences
So Young KimRobert J Linhardt

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved